An advisory committee for the Food and Drug Administration on Thursday voted unanimously (21 to 0) to recommend updating COVID-19 vaccines for the 2023-2024 period to be a monovalent formula targeting the latest omicron subvariant lineage of XBB.Such an update would apply to both primary series shots as well as boosters.
#back #comfortable #significantly #vaccinations #recommendations #disease-control #discussions #world-health-organization #continuously #manufacturers
[
add
]
[
|
|
...
]